136 related articles for article (PubMed ID: 32011702)
1. Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata.
Ceballos Garzon A; Amado D; Robert E; Parra Giraldo CM; Le Pape P
J Antimicrob Chemother; 2020 May; 75(5):1187-1193. PubMed ID: 32011702
[TBL] [Abstract][Full Text] [Related]
2. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
Ceballos-Garzon A; Monteoliva L; Gil C; Alvarez-Moreno C; Vega-Vela NE; Engelthaler DM; Bowers J; Le Pape P; Parra-Giraldo CM
J Antimicrob Chemother; 2022 Feb; 77(3):585-597. PubMed ID: 34893830
[TBL] [Abstract][Full Text] [Related]
3. Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.
Katiyar SK; Alastruey-Izquierdo A; Healey KR; Johnson ME; Perlin DS; Edlind TD
Antimicrob Agents Chemother; 2012 Dec; 56(12):6304-9. PubMed ID: 23027185
[TBL] [Abstract][Full Text] [Related]
4. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata.
Singh-Babak SD; Babak T; Diezmann S; Hill JA; Xie JL; Chen YL; Poutanen SM; Rennie RP; Heitman J; Cowen LE
PLoS Pathog; 2012; 8(5):e1002718. PubMed ID: 22615574
[TBL] [Abstract][Full Text] [Related]
5. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
Garcia-Effron G; Lee S; Park S; Cleary JD; Perlin DS
Antimicrob Agents Chemother; 2009 Sep; 53(9):3690-9. PubMed ID: 19546367
[TBL] [Abstract][Full Text] [Related]
6. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
Al-Baqsami ZF; Ahmad S; Khan Z
Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
[TBL] [Abstract][Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
8. Analysis of fks1 and fks2 gene mutations in invasive Candida glabrata strains from Pakistan.
Memon S; Ghanchi NK; Zafar U; Farooqi J; Zaka S; Jabeen K
Mycoses; 2023 Jan; 66(1):52-58. PubMed ID: 36106428
[TBL] [Abstract][Full Text] [Related]
9. Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.
Shields RK; Nguyen MH; Press EG; Updike CL; Clancy CJ
Antimicrob Agents Chemother; 2013 Aug; 57(8):3528-35. PubMed ID: 23669387
[TBL] [Abstract][Full Text] [Related]
10. Assessment of caspofungin susceptibility of Candida glabrata by the Etest®, CLSI, and EUCAST methods, and detection of FKS1 and FKS2 mutations.
Bourgeois N; Laurens C; Bertout S; Balard Y; Krasteva D; Rispail P; Lachaud L
Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1247-52. PubMed ID: 24522619
[TBL] [Abstract][Full Text] [Related]
11. Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility.
Healey KR; Katiyar SK; Castanheira M; Pfaller MA; Edlind TD
Antimicrob Agents Chemother; 2011 Aug; 55(8):3947-9. PubMed ID: 21628537
[TBL] [Abstract][Full Text] [Related]
12.
Nunnally NS; Etienne KA; Angulo D; Lockhart SR; Berkow EL
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481447
[TBL] [Abstract][Full Text] [Related]
13. Drug susceptibility profile of Candida glabrata clinical isolates from Iran and genetic resistant mechanisms to caspofungin.
Amanloo S; Shams-Ghahfarokhi M; Ghahri M; Razzaghi-Abyaneh M
Rev Iberoam Micol; 2018; 35(2):88-91. PubMed ID: 29685375
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous Mutational Frequency and
Shields RK; Kline EG; Healey KR; Kordalewska M; Perlin DS; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373796
[TBL] [Abstract][Full Text] [Related]
15. Novel
Hou X; Healey KR; Shor E; Kordalewska M; Ortigosa CJ; Paderu P; Xiao M; Wang H; Zhao Y; Lin LY; Zhang YH; Li YZ; Xu YC; Perlin DS; Zhao Y
Emerg Microbes Infect; 2019; 8(1):1619-1625. PubMed ID: 31711370
[TBL] [Abstract][Full Text] [Related]
16. Absence of Azole or Echinocandin Resistance in Candida glabrata Isolates in India despite Background Prevalence of Strains with Defects in the DNA Mismatch Repair Pathway.
Singh A; Healey KR; Yadav P; Upadhyaya G; Sachdeva N; Sarma S; Kumar A; Tarai B; Perlin DS; Chowdhary A
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610199
[No Abstract] [Full Text] [Related]
17. Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China.
Li Y; Hou X; Li R; Liao K; Ma L; Wang X; Ji P; Kong H; Xia Y; Ding H; Kang W; Zhang G; Li J; Xiao M; Li Y; Xu Y
BMC Microbiol; 2023 Nov; 23(1):341. PubMed ID: 37974063
[TBL] [Abstract][Full Text] [Related]
18. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin.
Toutounji M; Tokajian S; Khalaf RA
Fungal Genet Biol; 2019 Jun; 127():12-22. PubMed ID: 30794951
[TBL] [Abstract][Full Text] [Related]
19. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.
Thompson GR; Wiederhold NP; Vallor AC; Villareal NC; Lewis JS; Patterson TF
Antimicrob Agents Chemother; 2008 Oct; 52(10):3783-5. PubMed ID: 18676885
[TBL] [Abstract][Full Text] [Related]
20. Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.
Vatanshenassan M; Arastehfar A; Boekhout T; Berman J; Lass-Flörl C; Sparbier K; Kostrzewa M
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]